M
Marlene Smurzynski
Researcher at Harvard University
Publications - 23
Citations - 1983
Marlene Smurzynski is an academic researcher from Harvard University. The author has contributed to research in topics: Cohort & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 17, co-authored 23 publications receiving 1860 citations. Previous affiliations of Marlene Smurzynski include University of North Carolina at Chapel Hill & George Washington University.
Papers
More filters
Journal ArticleDOI
The prevalence and incidence of neurocognitive impairment in the HAART era.
Kevin Robertson,Marlene Smurzynski,Thomas D. Parsons,Kunling Wu,Ronald J. Bosch,Julia W. Wu,Justin C. McArthur,Ann C. Collier,Scott R. Evans,Ronald J. Ellis +9 more
TL;DR: The association of previous advanced immunosuppression with prevalent and sustained impairment suggests that there is a non-reversible component of neural injury that tracks with a history of disease progression, and suggests that restoring immunocompetence increases the likelihood of neurocognitive recovery.
Journal ArticleDOI
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.
Marlene Smurzynski,Kunling Wu,Scott Letendre,Kevin Robertson,Ronald J. Bosch,David B. Clifford,Scott R. Evans,Ann C. Collier,Michael Taylor,Ronald J. Ellis +9 more
TL;DR: Clinically this means antiretroviral regimens could be designed to optimize estimated CNS penetration without sacrificing virologic and immunologic benefits, and some people may require more than three anti-HIV drugs to treat HIV in the CNS.
Journal ArticleDOI
Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions
Elizabeth C. Tilson,Victoria Sanchez,Chandra L. Ford,Marlene Smurzynski,Peter A. Leone,Kimberley Fox,Kimberley Fox,Kathleen Irwin,William C. Miller +8 more
TL;DR: Perceived barriers to care included lack of knowledge of STDs and available services, cost, shame associated with seeking services, long clinic waiting times, discrimination, and urethral specimen collection methods.
Journal ArticleDOI
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.
Christopher D. Pilcher,J. Todd McPherson,Peter A. Leone,Marlene Smurzynski,Judy Owen-O’Dowd,Amy L. Peace-Brewer,Juanita Harris,Charles B. Hicks,Joseph J. Eron,Susan A. Fiscus +9 more
TL;DR: Findings suggest the widespread diagnosis of acute HIV infections in a routine testing population is not only possible but feasible using specimen pooling and nucleic acid testing.
Journal ArticleDOI
No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
Heather J. Ribaudo,Constance A. Benson,Yu Zheng,Susan L. Koletar,Ann C. Collier,Judith J. Lok,Marlene Smurzynski,Ronald J. Bosch,Barbara Bastow,Jeffrey T. Schouten +9 more
TL;DR: Although the risk of MI decreased over time, there was no evidence to suggest a time-dependent abacavir effect, and Classic cardiovascular disease (CVD) risk factors were the strongest predictors of MI.